NCT00345345 2022-05-03
Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte Leukemia
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
3 trialsNCT00002643 2013-02-01
Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
National Cancer Institute (NCI)
Phase 2 Completed
NCT00771433 2011-05-13
G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed